ALEC (Alector Inc.) Earnings per share for the last four quarters
Developing treatments for neurodegeneration requires colossal expenditures and faces stringent patent protection, which limits the number of players. This chart of stock quotes demonstrates the EPS TTM dynamics, which currently stands at 133.30. The Alector, Inc. (ALEC) business is independent of economic cycles and GDP, and scaling through alliances with pharma behemoths minimizes cost growth, although it delays the operating leverage effect.
Alector Therapeutics - analytical breakdowns and key metrics (ALEC)
- market value and analyst target forecast:
- business market valuation indicators:
- business book valuation details:
- debt and liquidity data:
- net income and valuation ratios data:
ALEC - Net Profit|Projected Future Earnings Alector, Inc.|ALEC - Price to Earnings Ratio|Future Price to Earnings Alector, Inc.|ALEC - PEG Multiple|Company Value to EBITDA Alector Inc.|ALEC - Operating profit EBITDA|Net earnings per share for the last 12 months Alector|ALEC - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months alector.com|ALEC - Earnings growth in current year|Expected net earnings per share growth next year Alector, Inc.
- revenue and sales details:
Initial company analysis:Alector, ALEC
Monitoring real business returns is critical for capital protection amid volatility. This indicator captures the percentage change in net income per share over the trailing twelve months relative to the previous year. By analyzing the EPS TTM YoY growth rate, an investor identifies the pace of capital expansion or contraction. For Alector, Inc. (ALEC), such fluctuations reflect the financial efficiency of developing Alzheimer's treatments within a strategic pharmaceutical alliance.
Competitor analysis for Alector, Inc.
biogen.com (BIIB) - Net earnings per share for the last 12 months|NBIX (Neurocrine Biosciences, Inc.) - Net earnings per share for the last 12 months|RGC: Earnings per share for the last four quarters|Earnings per share for the last twelve months Axsome Therapeutics Inc|Net earnings per one share for the last twelve months ACADIA Corp ACAD|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (vikingtherapeutics.com) - Earnings per share for the trailing year|Supernus - Net earnings per share for the last 12 months|Earnings per share for the trailing year CPRX|Denali Therapeutics Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Harmony Corp HRMY|Biohaven Ltd. (BHVN) - Earnings per share for the last twelve months|Earnings per share for the last 12 months AMLX|TRVI (Trevi Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Praxis Precision Medicines Inc (PRAX)|Net earnings per share for the last 12 months AVXL (Anavex Corp)|Net earnings per share for the last four quarters CeriBell EEG|Net earnings per share (EPS TTM) PRTA (Prothena Corporation)|Net earnings per share (EPS TTM) annexonbio.com ANNX|OMER - Earnings per share for the last twelve months|NGNE: Earnings per share for the last twelve months|ACIU: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Voyager Corp (VYGR)|NMRA (Neumora Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months scilexholding.com (SCLX)|Earnings per share for the last twelve months Tevogen Bio (TVGN)|alphacognition.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) CGTX (Cognition Therapeutics)|Inhibikase Pharma (IKT) - Net earnings per one share for the last twelve months|SAVA: Net earnings per share for the last 12 months|ASRT - Net earnings per share (EPS TTM)|coyatherapeutics.com (COYA) - Earnings per share for the last twelve months|Vistagen - Earnings per share for the trailing year|Earnings per share for the last twelve months Ovid Therapeutics Inc|Net earnings per one share for the last twelve months Acumen Pharmaceuticals, Inc ABOS|Net earnings per share (EPS TTM) CRVO|Net earnings per share (EPS TTM) alteritytherapeutics.com (ATHE)|Earnings per share for the last twelve months Clene CLNN|PepGen Inc - Earnings per share for the last twelve months|Jupiter Neurosciences Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Relmada Corp|ANVS: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Grace Therapeutics|Net earnings per share for the last 12 months AIFF|KLTO (ANEW Medical, Inc.) - Earnings per share for the last four quarters|Earnings per share for the last twelve months NeuroSense Therapeutics (NRSN)|RVPH - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months MetaVia MTVA|Earnings per share for the trailing year NRXS|HSDT: Net earnings per share for the last 12 months|Earnings per share for the trailing year PASG (Passage Bio, Inc.)|NEUP: Net earnings per share (EPS TTM)|NERV - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Athira Pharma, Inc.|Earnings per share for the last 12 months ADXN (addextherapeutics.com)|Net earnings per share (EPS TTM) ALZN|Net earnings per share for the last 12 months cyclerion.com CYCN|Protagenic Therapeutics, Inc. - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Pasithea Therapeutics Corp (KTTA)|Cortigent Medical - Net earnings per share (EPS TTM)|ATXI - Net earnings per share (EPS TTM)|BrainStorm Cell Therapeutics (BCLI) - Earnings per share for the last twelve months|CARA (Cara Therapeutics Inc.) - Earnings per share for the last twelve months|CHRO (Chromocell Therapeutics Corporation) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Eliem ELYM|Net earnings per share (EPS TTM) ITCI|Net earnings per share for the last 12 months longboardpharma.com LBPH|Earnings per share for the last twelve months Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings per share for the last 12 months|NeuroBo - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Sage Therapeutics Inc|SNPX (Synaptogenix, Inc.) - Net earnings per share for the last 12 months|trevena.com (TRVN) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Vigil Neuroscience Inc.|WENA: Earnings per share for the trailing year|Earnings per share for the last twelve months Cerevel (CERE)
